About Genenmed Inc

Mission

Our mission is to protect human lives from diseases using innovative technologies. We continuously pursue technology breakthrough.

About

We focus on development of various vaccines, gene therapies and therapeutic proteins including antibodies. We have successfully established a novel human cell line HesR6^® as a platform for the development of vaccines and gene therapies and also for the production of therapeutic monoclonal antibodies. Using our own adenoviral vector system AdBest^®, we can produce recombinant adenoviruses in a RCA-free manner.

We have our own technologies and experience for purifying adenovirus of clinical grade.

Using our own materials and technologies, the vaccines for MERS-coV, Ebola virus, HIV, influenza viruses and tuberculosis are under development. In addition, we are developing a gene therapy for promoting angiogenesis and a therapeutic monoclonal antibody for age-related macular degeneration (AMD) as well.